Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed ...

WHO’s new global guidance helps clinicians manage dengue, Zika, chikungunya, and yellow fever with protocols for fluids, ...

ICMR and Panacea Biotec conduct third phase trials for indigenous dengue vaccine in India with promising results.

After recovering from dengue fever, there are times when you experience prolonged fatigue, joint pain, hair loss, along with reduced immunity. These post-recovery symptoms can complicate the return to ...

A health alert has been issued for tourists traveling to Europe this summer as two potentially fatal diseases have been ...

Dengue, an Aedes mosquito-borne viral infection, has been a crucial public health concern during the monsoon in our country ...

The vaccine strain (TV003/TV005), originally developed by the US National Institutes of Health (NIH), has shown promising ...

World Health Organization (WHO) has just released the Integrated Guidelines on the Clinical Management of Arboviral Diseases -- a crucial step toward strengthening care for the millions of people ...

Dengue fever hits record numbers. Can it be controlled? : Goats and Soda Case counts are skyrocketing in countries like Brazil and Peru and the virus is popping up in new turf, from Florida to Iran.

Over 12 million cases of dengue fever were reported in 2024, the most ever. A study suggests climate change has likely played a significant role in the disease's expansion.

Phase-III trial of indigenous one-shot dengue vaccine by Panacea Biotec shows promising results in India, aiming for ...